• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌炎患者循环基质金属蛋白酶与组织抑制剂 TIMP-2 及肾功能的关系。

Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.

机构信息

Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.

Department of Drugs Form Technology, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Kidney Blood Press Res. 2021;46(6):749-757. doi: 10.1159/000519594. Epub 2021 Nov 19.

DOI:10.1159/000519594
PMID:34801997
Abstract

INTRODUCTION

Under physiological conditions, the myocardial extracellular matrix (ECM) is maintained by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). However, changes in the balance between MMPs and TIMPs can lead to pathological remodeling of the ECM, which contributes to cardiovascular and kidney diseases. The aim of our study was to assess levels of MMPs and TIMP-2 in patients with myocarditis and their relationship to renal function.

MATERIALS AND METHODS

Forty five patients with myocarditis who underwent CMR were included, comprising 11 with concurrent chronic kidney disease (CKD). Blood samples were obtained to assess serum levels of MMP-2, MMP-3, MMP-9, and TIMP-2.

RESULTS

Serum MMP-2, MMP-3, and TIMP-2 levels negatively correlated with the ejection fraction in patients with myocarditis, while MMP-3 levels correlated with longitudinal deformation (p < 0.05). Serum MMP-2, MMP-3, and TIMP-2 levels also negatively correlated with renal function, as assessed by the estimated glomerular filtration rate (eGFR) (p < 0.05). Patients with myocarditis and concurrent CKD had higher levels of MMP-2 and TIMP-2 than those without kidney damage.

CONCLUSIONS

(1) We demonstrated that MMP-2, MMP-3, and TIMP-2 concentrations were related to left-ventricular ejection fraction, and MMP-3 levels correlated with longitudinal deformation, indicating MMPs play an important role in the post-inflammatory remodeling of the myocardium. (2) A negative correlation between the eGFR and MMP-2, MMP-3, and TIMP-2 and a positive correlation between creatinine and MMP-3 levels indicate the role of MMPs and TIMP-2 in renal dysfunction.

摘要

简介

在生理条件下,心肌细胞外基质(ECM)由基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)维持。然而,MMPs 和 TIMPs 之间平衡的变化可导致 ECM 的病理性重塑,这有助于心血管和肾脏疾病的发生。本研究旨在评估心肌炎患者 MMPs 和 TIMP-2 的水平及其与肾功能的关系。

材料和方法

共纳入 45 例接受 CMR 的心肌炎患者,其中 11 例合并慢性肾脏病(CKD)。采集血样以评估血清 MMP-2、MMP-3、MMP-9 和 TIMP-2 水平。

结果

心肌炎患者血清 MMP-2、MMP-3 和 TIMP-2 水平与射血分数呈负相关,而 MMP-3 水平与纵向应变呈正相关(p < 0.05)。血清 MMP-2、MMP-3 和 TIMP-2 水平也与肾小球滤过率(eGFR)评估的肾功能呈负相关(p < 0.05)。合并 CKD 的心肌炎患者的 MMP-2 和 TIMP-2 水平高于无肾损伤患者。

结论

(1)我们表明 MMP-2、MMP-3 和 TIMP-2 浓度与左心室射血分数相关,MMP-3 水平与纵向应变相关,表明 MMPs 在心肌炎症后重塑中发挥重要作用。(2)eGFR 与 MMP-2、MMP-3 和 TIMP-2 呈负相关,与 MMP-3 水平呈正相关,表明 MMPs 和 TIMP-2 在肾功能障碍中的作用。

相似文献

1
Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.心肌炎患者循环基质金属蛋白酶与组织抑制剂 TIMP-2 及肾功能的关系。
Kidney Blood Press Res. 2021;46(6):749-757. doi: 10.1159/000519594. Epub 2021 Nov 19.
2
Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment.基质金属蛋白酶(MMP-2、9)及其组织抑制剂(TIMP-1、2)作为保守治疗慢性肾脏病(CKD)患儿应激反应和动脉粥样硬化形成的新型标志物。
Cell Stress Chaperones. 2011 Jan;16(1):97-103. doi: 10.1007/s12192-010-0214-x. Epub 2010 Sep 6.
3
Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.产妇血清在早产期间基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)之间的失衡。
PLoS One. 2012;7(11):e49042. doi: 10.1371/journal.pone.0049042. Epub 2012 Nov 8.
4
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.糖尿病肾病中的血清基质金属蛋白酶MMP - 2和MMP - 9以及金属蛋白酶组织抑制剂TIMP - 1和TIMP - 2
J Nephrol. 2007 Jul-Aug;20(4):444-52.
5
Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis.血液透析患者的血清金属蛋白酶 MMP-2、MMP-9 以及金属蛋白酶组织抑制剂 TIMP-1 和 TIMP-2。
Int Urol Nephrol. 2011 Jun;43(2):491-8. doi: 10.1007/s11255-009-9683-1. Epub 2009 Dec 2.
6
[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux].[膀胱输尿管反流患儿血清及尿液中特定金属蛋白酶及其组织抑制剂的浓度]
Pol Merkur Lekarski. 2010 Aug;29(170):88-92.
7
Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients.肾移植受者血浆基质金属蛋白酶-2(MMP-2)、蛋白酶组织抑制剂-1(TIMP-1)、TIMP-2以及尿MMP-2浓度升高与蛋白尿相关。
Transplant Proc. 2014 Oct;46(8):2636-9. doi: 10.1016/j.transproceed.2014.08.034.
8
Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.绝经前肥胖女性体内的基质金属蛋白酶2和9及其组织抑制剂1和2:与心脏功能的关系
Int J Obes (Lond). 2008 May;32(5):763-71. doi: 10.1038/sj.ijo.0803794. Epub 2008 Jan 15.
9
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.基质金属蛋白酶/金属蛋白酶组织抑制剂:基质成分蛋白水解决定因素的变化与高血压性心脏病的结构、功能及临床表现之间的关系
Circulation. 2006 May 2;113(17):2089-96. doi: 10.1161/CIRCULATIONAHA.105.573865. Epub 2006 Apr 24.
10
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.掌腱膜挛缩症患者血清和组织中的基质金属蛋白酶及金属蛋白酶组织抑制剂
Plast Reconstr Surg. 2003 Oct;112(5):1279-86. doi: 10.1097/01.PRS.0000081462.40448.49.

引用本文的文献

1
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.靶向纤维化:从分子机制到先进疗法
Adv Sci (Weinh). 2025 Jan;12(3):e2410416. doi: 10.1002/advs.202410416. Epub 2024 Dec 12.
2
The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart.慢性免疫抑制治疗对大鼠心脏组织形态学变化以及基质金属蛋白酶(MMP - 2和MMP - 9)与其抑制剂之间平衡的影响
Int J Mol Sci. 2024 Apr 18;25(8):4468. doi: 10.3390/ijms25084468.
3
Effect of SARS-CoV-2 Infection and BNT162b2 Vaccination on the mRNA Expression of Genes Associated with Angiogenesis.
SARS-CoV-2 感染和 BNT162b2 疫苗接种对与血管生成相关基因的 mRNA 表达的影响。
Int J Mol Sci. 2023 Nov 8;24(22):16094. doi: 10.3390/ijms242216094.
4
Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Metalloproteinase 1 (TIMP-1) Genes as a Diagnostic and Prognostic Marker of Heart Failure Due to Ischemic Heart Disease.金属蛋白酶9(MMP-9)和组织金属蛋白酶1(TIMP-1)基因的转录活性作为缺血性心脏病所致心力衰竭的诊断和预后标志物
Biomedicines. 2023 Oct 13;11(10):2776. doi: 10.3390/biomedicines11102776.
5
The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects-A Review of Literature.钙调神经磷酸酶抑制剂对心脏 MMPs 活性的影响及其副作用——文献综述。
Int J Mol Sci. 2023 Jun 18;24(12):10291. doi: 10.3390/ijms241210291.
6
The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress.心肌纤维化的发病机制:研究进展综述。
Int J Mol Sci. 2022 Feb 27;23(5):2617. doi: 10.3390/ijms23052617.